Tamoxifen Therapy for Retroperitoneal Fibrosis
- Eric F.H. van Bommel, MD, PhD; and
- Tadek R. Hendriksz, MD
- From Albert Schweitzer Hospital, NL-3300 AK Dordrecht, the Netherlands.
IN RESPONSE:
We agree with Drs. Vaglio, Greco, and Buzio that standardized classification criteria for RPF are lacking. However, our own experience and interpretation of the literature led us to believe that, in a subset of patients with presumed idiopathic disease, the condition is actually a local complication of advanced atherosclerosis (1). The higher incidence of symptomatic atherosclerotic disease in men may also explain the increased incidence of RPF in men. Some researchers even suggest that the future of this disorder lies …
RSS Feeds









